REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aquila Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: AQUILA PHARMA Gyogyszerkereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Aquila Pharma Kft. is a company based in Hungary, with its head office in Mateszalka. It operates in the Pharmacies and Drug Stores sector. It was first established on July 25, 2015. Aquila Pharma Kft. currently employs 6 (2024) people. The company’s latest financial report indicates a net sales revenue increase of 11.68% in 2023. Its’ total assets recorded a negative growth of 13.38%. The net profit margin of Aquila Pharma Kft. decreased by 8.9% in 2023.

Headquarters
Kalvin ter 7.
Mateszalka; Szabolcs-Szatmar-Bereg; Postal Code: 4700

Contact Details: Purchase the Aquila Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Aquila Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Aquila Pharma Kft. report to view the information.
Registered Capital:
Purchase the Aquila Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Aquila Pharma Kft. report to view the information.
Incorporation Date:
July 25, 2015
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Fecske Patika Bt.
Company Performance
Financial values in the chart are available after Aquila Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.68%▲
Total operating revenue
11.45%▲
Operating profit (EBIT)
-54.33%▼
EBITDA
-45.95%▼
Net Profit (Loss) for the Period
-50.41%▼
Total assets
-13.38%▼
Total equity
7.82%▲
Operating Profit Margin (ROS)
-9.17%▼
Net Profit Margin
-8.9%▼
Return on Equity (ROE)
-8.51%▼
Quick Ratio
0.84%▲
Cash Ratio
0.56%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo